Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective We aimed to compare cerebral beta-amyloid protein (Aβ) positivity rate and amyloid accumulation pattern on amyloid positron emission tomography (PET) between mild cognitive impairment (MCI) subtypes, i.e. amnestic mild cognitive impairment (aMCI) and non-amnestic mild cognitive impairment (naMCI).Methods The study participants were 34 naMCI patients and age-, sex- and education-matched 68 aMCI patients (1:2 ratio) who visited the Dementia and Age-Associated Cognitive Decline Clinic of the Seoul National University Hospital. All participants received comprehensive clinical and neuropsychological assessments and [<sup>18</sup>F] florbetaben PET.Results Aβ positivity rate of naMCI group (26.5%) was significantly lower than that of aMCI group (64.7%). Among Aβ positive individuals, there was no difference in Aβ accumulation pattern between naMCI and aMCI.Conclusion The findings suggest that MCI subtypes based on impaired cognitive domains have a differential association with brain Aβ deposition, a core pathology of AD. Amnestic subtype of MCI are more closely associated with cerebral Aβ deposition compared to nonamnestic subtype. In contrast, the pattern of amyloid deposition does not appear to have any difference between the subtypes.
Abstract
Objective We aimed to compare cerebral beta-amyloid protein (Aβ) positivity rate and amyloid accumulation pattern on amyloid positron emission tomography (PET) between mild cognitive impairment (MCI) subtypes, i.e. amnestic mild cognitive impairment (aMCI) and non-amnestic mild cognitive impairment (naMCI).Methods The study participants were 34 naMCI patients and age-, sex- and education-matched 68 aMCI patients (1:2 ratio) who visited the Dementia and Age-Associated Cognitive Decline Clinic of the Seoul National University Hospital. All participants received comprehensive clinical and neuropsychological assessments and [<sup>18</sup>F] florbetaben PET.Results Aβ positivity rate of naMCI group (26.5%) was significantly lower than that of aMCI group (64.7%). Among Aβ positive individuals, there was no difference in Aβ accumulation pattern between naMCI and aMCI.Conclusion The findings suggest that MCI subtypes based on impaired cognitive domains have a differential association with brain Aβ deposition, a core pathology of AD. Amnestic subtype of MCI are more closely associated with cerebral Aβ deposition compared to nonamnestic subtype. In contrast, the pattern of amyloid deposition does not appear to have any difference between the subtypes.
참고문헌 (20)
- Winblad B, "Mild cognitive impairment–beyond controversies, towards a consensus : report of the International Working Group on Mild Cognitive Impairment", J Intern Med, 256, pp.240~246 (2004)
- Petersen RC, "Mild cognitive impairment as a clinical entity and treatment target", Arch Neurol, 62, pp.1160~1163 (2005)
- Gauthier S, "Mild cognitive impairment", Lancet, 367, pp.1262~1270 (2006)
- Petersen RC, "Mild cognitive impairment", Continuum(Minneap Minn), 22, pp.404~418 (2016)
- Roberts R, "Classification and epidemiology of MCI", Clin Geriatr Med, 29, pp.753~772 (2013)
- Nordlund A, "Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study", J Neurol Neurosurg Psychiatry, 81, pp.541~546 (2010)
- Mitchell J, "Outcome in subgroups of mild cognitive impairment(MCI)is highly predictable using a simple algorithm", Neurology, 256, pp.1500~1509 (2009)
- Rasquin S, "Predictive accuracy of MCI subtypes for Alzheimer’s disease and vascular dementia in subjects with mild cognitive impairment : a 2-year follow-up study", Dement Geriatr Cogn Disord, 19, pp.113~119 (2005)
- Patricio CM, "Concordance between 11C-PIB-PET and clinical diagnosis in a memory clinic", Am J Alzheimers Dis Other Demen, 30, pp.599~606 (2015)
- Jiménez-Bonilla JF, "Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET", CT in amnestic and nonamnestic mild cognitive impairment patients, 2016, pp.37, 1189~1196
- Banzo I, "Patterns of 11C-PIB cerebral retention in mild cognitive impairment patients", Rev Esp Med Nucl Imagen Mol, 35, pp.171~174 (2016)
- Wolk DA, "Amyloid imaging in mild cognitive impairment subtypes", Ann Neurol, 65, pp.557~568 (2009)
- Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
- Petersen RC, "Current concepts in mild cognitive impairment", Arch Neurol, 58, pp.1985~1992 (2001)
- Lee DY, "A normative study of the CERAD neuropsychological assessment battery in the Korean elderly", J Int Neuropsychol Soc, 10, pp.72~81 (2004)
- Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K)clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.47~53 (2002)
- Morris JC, "The Clinical Dementia Rating(CDR) : current version and scoring rules", Neurology, 41, pp.1588~1592 (1991)
- DeCarli C, "Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia", Neurology, 63, pp.220~227 (2004)
- Sabri O, "Beta-amyloid imaging with florbetaben", Clin Transl Imag, 3, pp.13~26 (2015)
- Busse A, "Mild cognitive impairment : long-term course of four clinical subtypes", Neurology, 67, pp.2176~2185 (2006)